메뉴 건너뛰기
Targeted Oncology
Volumn 5, Issue 2, 2010, Pages 73-74
Renal cell carcinoma: Ten years of significant advances
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOGENESIS INHIBITOR; IPILIMUMAB;
EID: 77957982592     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-010-0150-9     Document Type: Editorial
Times cited : (4)
References (8)
  • 1
    • 62849128369 scopus 로고    scopus 로고
    • Renal cell carcinoma
    • Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373 (9669):1119-1132
    • (2009) Lancet , vol.373 , Issue.9669 , pp. 1119-1132
    • Rini, B.I.1    Campbell, S.C.2    Escudier, B.3
  • 2
    • 33644847440 scopus 로고    scopus 로고
    • Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
    • Faivre S, Delbaldo C, Vera K et al (2006) Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 24 (1):25-35
    • (2006) J. Clin. Oncol. , vol.24 , Issue.1 , pp. 25-35
    • Faivre, S.1    Delbaldo, C.2    Vera, K.3
  • 3
    • 0042343801 scopus 로고    scopus 로고
    • A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
    • Yang JC, Haworth L, Sherry RM et al (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349 (5):427-434
    • (2003) N Engl. J. Med. , vol.349 , Issue.5 , pp. 427-434
    • Yang, J.C.1    Haworth, L.2    Sherry, R.M.3
  • 4
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with Ipilimumab in patients with metastatic melanoma
    • doi:10.1056/NEJMoa1003466, Jun. 14
    • Hodi FS, O'Day SJ, McDermott DF et al (2010) Improved survival with Ipilimumab in patients with metastatic melanoma. N Engl J Med Jun. doi:10.1056/NEJMoa1003466, Jun. 14
    • (2010) N Engl. J. Med. Jun
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 5
    • 37349072460 scopus 로고    scopus 로고
    • Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis
    • Yang JC, Hughes M, Kammula U et al (2007) Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother 30 (8):825-830
    • (2007) J. Immunother. , vol.30 , Issue.8 , pp. 825-830
    • Yang, J.C.1    Hughes, M.2    Kammula, U.3
  • 6
    • 34247260551 scopus 로고    scopus 로고
    • Immunotherapy for renal cell cancer
    • Yang JC, Childs R (2006) Immunotherapy for renal cell cancer. J Clin Oncol 24 (35):5576-5583
    • (2006) J. Clin. Oncol. , vol.24 , Issue.35 , pp. 5576-5583
    • Yang, J.C.1    Childs, R.2
  • 7
    • 77958021822 scopus 로고    scopus 로고
    • http://clinicaltrials.gov/ct2/show/NCT01014234?term=rapamycin& rank=5
  • 8
    • 77952962769 scopus 로고    scopus 로고
    • Development of personalized tumor biomarkers using massively parallel sequencing
    • Leary RJ, Kinde I, Diehl F et al (2010) Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2 (20):20ra14
    • (2010) Sci. Transl Med. , vol.2 , Issue.20
    • Leary, R.J.1    Kinde, I.2    Diehl, F.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.